TY - CHAP M1 - Book, Section TI - AMPHETAMINES A1 - Albertson, Timothy E. A2 - Olson, Kent R. A2 - Anderson, Ilene B. A2 - Benowitz, Neal L. A2 - Blanc, Paul D. A2 - Clark, Richard F. A2 - Kearney, Thomas E. A2 - Kim-Katz, Susan Y. A2 - Wu, Alan H. B. Y1 - 2018 N1 - T2 - Poisoning & Drug Overdose, 7e AB - Dextroamphetamine (Dexedrine) and methylphenidate (Ritalin) are used for the treatment of narcolepsy and for attention-deficit disorders in children. Methamphetamine ("crank," "speed"), 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"), paramethoxyamphetamine (PMA), and several other amphetamine derivatives, as well as a number of prescription drugs, are used as illicit stimulants and hallucinogens (see also "Lysergic Acid Diethylamide [LSD] and Other Hallucinogens"). "Ice" is a high purity, smokable crystalline form of methamphetamine. Methamphetamine precursors such as pseudoephedrine, ephedrine, and other over-the-counter decongestants are discussed on Pseudoephedrine, Phenylephrine, and other Decongestants. Several amphetamine-related drugs (benzphetamine, diethylpropion, phendimetrazine, phenmetrazine, and phentermine) are marketed as prescription anorectic medications for use in weight reduction (Table II–1). Fenfluramine and dexfenfluramine were marketed as anorectic medications but were withdrawn from the market in 1997 because of concerns about cardiopulmonary toxicity with long-term use. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1179990415 ER -